The newsletters offer you the access to the latest information regarding HeartLogic™ Heart Failure Diagnostic as well as to a set of patient cases.
In this issue we look at an update on the COVID-19 guidance issued by international societies of cardiology for HF patients as well as the latest evidence of HeartLogic use.
In this issue, we focus on HeartLogic posters and its use in the management of HF patients, that were presented at the latest Annual Congress of the Heart Failure Society of America (HFSA 2020)
In September, we share with you the latest HeartLogic™ Clinical Evidence presented during the ESC Congress 2020: an analysis from RE-HEART (HeartLogic Spanish Registry) and from the Italian Registry on HeartLogic.
In our July issue, we will share the recommendations of the main cardiovascular associations to manage heart failure during the Covid-19 pandemic.
In this June issue, you have the opportunity to access the latest HeartLogic clinical evidence, accepted at the ESC-HFA Congress 2020.
It is our pleasure to share with you the latest findings about HeartLogic use in clinical practice just published in Clinical Cardiology.
In this very tough period in all European countries due to Covid-19 emergency,
we would like to review with you assessment and treatments strategies in case of HeartLogic™ alert.
In this issue we would like to deepen the correlation between HeartLogic algorithm and NT-proBNP biomarker for HF diagnosis.
In the last issue we reviewed the clinical evidence on the feasibility of automatic heart sounds measurement with ICD-embedded accelerometer.